- Home
- JMSB vs ARCT Comparison
JMSB vs ARCT Comparison
Compare JMSB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- ARCT
- Stock Information
- Founded
- JMSB 2005
- ARCT 2013
- Country
- JMSB United States
- ARCT United States
- Employees
- JMSB N/A
- ARCT N/A
- Industry
- JMSB Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- ARCT Health Care
- Exchange
- JMSB Nasdaq
- ARCT Nasdaq
- Market Cap
- JMSB 268.9M
- ARCT 298.3M
- IPO Year
- JMSB N/A
- ARCT N/A
- Fundamental
- Price
- JMSB $17.12
- ARCT $10.98
- Analyst Decision
- JMSB
- ARCT Strong Buy
- Analyst Count
- JMSB 0
- ARCT 7
- Target Price
- JMSB N/A
- ARCT $57.80
- AVG Volume (30 Days)
- JMSB 22.1K
- ARCT 372.7K
- Earning Date
- JMSB 04-23-2025
- ARCT 05-12-2025
- Dividend Yield
- JMSB 2.94%
- ARCT N/A
- EPS Growth
- JMSB 472.90
- ARCT N/A
- EPS
- JMSB 1.24
- ARCT N/A
- Revenue
- JMSB $54,782,000.00
- ARCT $152,310,000.00
- Revenue This Year
- JMSB N/A
- ARCT N/A
- Revenue Next Year
- JMSB N/A
- ARCT $44.93
- P/E Ratio
- JMSB $13.84
- ARCT N/A
- Revenue Growth
- JMSB 50.81
- ARCT N/A
- 52 Week Low
- JMSB $13.81
- ARCT $8.04
- 52 Week High
- JMSB $26.52
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- JMSB 59.33
- ARCT 42.59
- Support Level
- JMSB $16.67
- ARCT $10.70
- Resistance Level
- JMSB $17.83
- ARCT $13.10
- Average True Range (ATR)
- JMSB 0.57
- ARCT 0.83
- MACD
- JMSB 0.22
- ARCT -0.05
- Stochastic Oscillator
- JMSB 78.55
- ARCT 9.46
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc provides banking services. The company offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.